Answers are grounded in this paper and cite their sources.
Aim: The aim of the present study was to evaluate the efficacy of topically applied1% phenytoin as an adjunctive treatment in Stage II or III, Grade A periodontitispatients. Subjects and Methods: This study was designed as a split-mouth randomizedcontrolled clinical, carried out on 20 patients of both sexes (12 female and 8 male),aged from (33-55) years with mean age (43.25± 6.64) with stage II or III, grade Aperiodontitis. Patients’ sides were classified randomly into the following groups: Group < /div>I: included 20 sides with Stage II or III, Grade A periodontitis patients treated byscaling and root planing alone. Group II: included 20 sides with Stage II or III, Grade Aperiodontitis patients treated by scaling and root planing combined with 1% phenytoingel. All patients were evaluated clinically at; baseline, 1, 3 and 6 months using plaqueindex (PI), gingival index (GI), probing pocket depth (PPD), clinical attachmentlevel (CAL) and radiographically by evaluation of the marginal bone level (MBL).Results: Phenytoin group: showed reduction in PPD and CAL, as well as significantgain in MBL than group I at 6 months after treatment Conclusion: The adjunctiveuse of 1% PHT in-situ gel exhibited an attractive effect on probing pocket depthreduction clinical attachment gain in non-surgical treatment of stage II and III grade Aperiodontitis. Phenytoin 1% in-situ gel seemed to have an osteogenic efficacy throughthe reported marginal bone gain in treatment of stage II and III grade A periodontitispatients.
No takes yet. Share an insight, caveat, or question.
Salatein et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: